1. Home
  2. NRSN vs RVP Comparison

NRSN vs RVP Comparison

Compare NRSN & RVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

HOLD

Current Price

$0.88

Market Cap

29.8M

Sector

Health Care

ML Signal

HOLD

Logo Retractable Technologies Inc.

RVP

Retractable Technologies Inc.

HOLD

Current Price

$0.84

Market Cap

24.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRSN
RVP
Founded
2017
1994
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.8M
24.5M
IPO Year
2021
2001

Fundamental Metrics

Financial Performance
Metric
NRSN
RVP
Price
$0.88
$0.84
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$14.00
N/A
AVG Volume (30 Days)
489.0K
44.3K
Earning Date
04-06-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$37,900,578.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.81
$0.59
52 Week High
$2.60
$1.14

Technical Indicators

Market Signals
Indicator
NRSN
RVP
Relative Strength Index (RSI) 37.38 46.57
Support Level $0.86 $0.79
Resistance Level $1.24 $0.84
Average True Range (ATR) 0.12 0.04
MACD -0.03 0.00
Stochastic Oscillator 7.89 44.82

Price Performance

Historical Comparison
NRSN
RVP

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About RVP Retractable Technologies Inc.

Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.

Share on Social Networks: